PatientsVille.com Logo

Soft and Fascia

PatientsVille

Soft Symptoms and Causes

Your Soft tissues connect, support, or surround other tissues. Examples include your muscles, tendons, fat, and blood vessels. Soft tissue sarcoma is a cancer of these Soft tissues. There are many kinds, based on the type of tissue they started in. They may cause a lump or swelling in the Soft tissue. Sometimes they spread and can press on nerves and organs, causing problems such as pain or trouble breathing.

No one knows exactly what causes these cancers. They are not common, but you have a higher risk if you have been exposed to certain chemicals, have had radiation therapy, or have certain genetic diseases.

Doctors diagnose Soft tissue sarcomas with a biopsy. Treatments include surgery to remove the tumor, radiation therapy, chemotherapy, or a combination.

NIH: National Cancer Institute

Check out the latest treatments for soft

soft treatment research studies

Fascia clinical trials, surveys and public health registries


Find Drug Side Effect reports



Fascia Side Effects

Graft Infection (9)
Vaginal Infection (8)
Urinary Tract Infection (2)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

My hands are peelling

My husband recently had a large soft tissue sarcoma removed from his thigh and is due to begin treatment. He now has a second bad eye 'infection' and is poorly -can anyone tell me if this is normal? Thankyou

STOOL SOFTENERS WITHOUT HARMFUL SIDE EFFECTS AFFECTING OTHER PARTS OF ONE'S BODY

A doctor subscribed this medication to me for a flu. On the 3rd day I had soft tissue blisters in my nose and my nose was swollen. Also my glands under my neck/jaw were sore. The 4th day my checks and jaws also swole up. *DONT_KNOW*

After taking Miralax with<strong></strong><span style='text-decoration: underline;'> not enough water, my stools have been for over a week now sticky, soft and need for frequent(4-6) bowel movements a day.

Been taking Miralax for about three weeks - a capful measure each morning, to relieve painful cramping resultant from seizure medication. It gave almost instant relief for the pain; stool is very soft and almost liquid. I plan to reduce amount of M

Even though i maintain regular defeaication with fibre and senna 2 tabs when i go the toilet i am unable to defecate; the rectum- anal bulges and i cannot push it out even though the faeces is soft.;when i do manage there is a ter

Have been taking salofalk for a month, bleeding from the bowel, severe pains in the stomach, mild chest pain, constapated stool soft, I think i'm incontinent of bm, my bowels are not moving right, and i do have colitis

I am a soft tissue sarcoma patient.I have had my chemo cycle with yondelis for the first time.I am feeling very weak n my liver function test is also not good.SGOT,SGPT and BILIRUBIN is effected.fever in not going down.

I get gassy and I get soft stool with mucus is that normal

I had a colcoplast penile prosthesis one touch device inserted in July 2008 at New York. Currently the inflated cylinders are not holding properly and it becomes soft probably due valve or pump malfunction?? I have to keep pumping about 30-40 times

I have a constantly sore anus. My stools can be hard and small as stones and or soft. I find I have little bouts of urination, sometimes just six dribbles.In the night I'll waken up to go, then go back to sleep and waken up at the beginning of a urin

I have a friend that has one more dose left to take..she has it in the bones as well as the adrenals and some other areas of soft tissue..her sternum area hurts alot and her abdomen hurts and doubles her over..all of these sites have turmors..I think

Soft Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids
Conditions: Asthma;   Obesity
Interventions: Dietary Supplement: omega-3 polyunsaturated fatty acids;   Dietary Supplement: placebo
Outcome Measures: Asthma Control Questionnaire (Juniper);   Asthma symptom exacerbation, plasma membrane PUFA composition, spirometry, peak flow, forced oscillation
2 Unknown  Efficacy of a Novel Multivitamin-Mineral Supplement in Preventing Vitamin Deficiency in Postoperative Bariatric Patients
Condition: Bariatric Surgery Candidate
Interventions: Dietary Supplement: AquaVanta Chewable Tablet;   Dietary Supplement: Flinstones Complete;   Dietary Supplement: Nature Made Calcium Softgels;   Dietary Supplement: Twin Labs Iron Caps;   Dietary Supplement: Rexall Vitamin B12 Tablet
Outcome Measures: Plasma vitamin and mineral levels;   Questionnaire regarding the palatability of the formulation and the ease of administration of the formats and dosing schedule
3 Recruiting The Relationship of Essential Fatty Acids to Adult ADHD: The OCEAN Study (Oils and Cognitive Effects in Adult ADHD Neurodevelopment)
Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: Dietary Supplement: Experimental fatty acid supplementation;   Dietary Supplement: Placebo comparator: MCT oil softgel
Outcome Measures: The relationship of essential fatty acids to cognitive and electrophysiological measures of brain and behavioural function;   The relationship of essential fatty acids to ADHD
4 Recruiting Effect of Vitamin K Supplementation on Markers of Diabetes Risk in Obese Children
Conditions: Obesity;   Insulin Resistance;   Insulin Sensitivity;   Beta-Cell Dysfunction;   Prediabetes
Interventions: Dietary Supplement: Placebo-Control;   Dietary Supplement: Low-Dose Vitamin K2 (menaquinone-7; 45 mcg/d);   Dietary Supplement: High-Dose Vitamin K2 (menaquinone-7; 90 mcg/d)
Outcome Measures: Change in insulin sensitivity;   Change in beta-cell function;   Change in coagulation;   Changes in serum adipokine concentrations;   Effects of sex, race, bone age, and pubertal stage on changes in glucose metabolism (insulin sensitivity and beta-cell function)
5 Recruiting Efficacy Study of Ginger (Zingiber Officinale) Extract to Manage Nausea in Cancer Patients Receiving High Emetogenic Treatments and Standard Anti-emetogenic Therapy
Conditions: Cancer;   Nausea;   Vomiting
Intervention: Dietary Supplement: Standardized Ginger extract
Outcome Measures: To evaluate the efficacy of Ginger in protecting patients from delayed nausea (incidence of no delayed nausea and non-significant delayed nausea);   Protection from delayed vomiting (number of emetic episodes in delayed phase);   Use of antiemetic rescue medication.;   Overall fatigue assessment (BFI questionnaire)
6 Recruiting Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
Condition: Transthyretin (TTR) Amyloid Cardiomyopathy
Interventions: Drug: Tafamidis;   Drug: Placebo
Outcome Measures: All-cause mortality and frequency of cardiovascular-related hospitalization;   6-Minute Walk Test (6MWT).;   Kansas City Cardiomyopathy Questionnaire (KCCQ);   Cardiovascular-related mortality;   Frequency of cardiovascular-related hospitalization;   All-cause mortality;   TTR stabilization at Month 1
7 Recruiting Effect of Cardio Mato (a Tomato Extracted Lycopene) on Blood Pressure and Serum Lycopene, Phytofluene, and Phytoene Levels in Pre-hypertensive Otherwise Healthy Subjects
Condition: Prehypertension
Interventions: Dietary Supplement: Cardio Mato (tomato extracted lycopene);   Dietary Supplement: Placebo
Outcome Measures: The effect Lyc-O-Mato on the blood pressure of pre-hypertensive otherwise healthy subjects compared to the placebo group following 12 weeks of treatment;   The effect Cardio Mato on the blood pressure of Pre-hypertensive otherwise healthy subjects compared to the placebo group following 4 and 8 weeks of treatment;   The correlation between B.P changes in the Cardio Mato or placebo treatment arms during the study with serum lycopene phytofluene, and phytoene levels
8 Recruiting Saw Palmetto: Symptom Management for Men During Radiation Therapy
Condition: Prostate Cancer
Intervention: Drug: Saw Palmetto
Outcome Measures: Feasibility;   Efficacy;   Safety
9 Recruiting Efficacy and Safety of Oral Rigosertib in Transfusion-dependent, Low or Int-1 or Trisomy 8 Int-2 Myelodysplastic Syndrome
Conditions: Myelodysplastic Syndrome;   MDS;   Trisomy 8
Intervention: Drug: rigosertib
Outcome Measures: Number of units of red blood cell transfusions;   Number of Adverse Events (AEs);   Bone marrow blasts;   Complete blood count
10 Unknown  Pharmacokinetics of MCS in Healthy Volunteers
Condition: Healthy
Intervention: Drug: MCS-2 soft-gel capsule
Outcome Measures: Serum MCS and other components levels;   Incidence of treatment-emergent adverse events
11 Recruiting Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Conditions: Ruptured Cerebral Aneurysm;   Ruptured Berry Aneurysm
Interventions: Drug: Nimodipine;   Drug: Nimodipine Microparticles
Outcome Measures: Dose Escalation Period;   PK measurements
12 Recruiting Treatment of Anxiety and Anorexia Nervosa in Adolescents
Conditions: Anxiety;   Anorexia Nervosa
Interventions: Drug: Fish oil;   Procedure: Massage therapy;   Drug: Placebo pill
Outcome Measures: Tolerability of fish oil supplementation in adolescents with anorexia nervosa.;   Improvement in trait anxiety in subjects receiving a combination of omega-3 PUFA supplementation and massage therapy plus standard of careas compared to subjects receiving standard of care treatment alone (controls).
13 Recruiting Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF)
Condition: Cystic Fibrosis
Interventions: Dietary Supplement: ECGC;   Dietary Supplement: Tocotrienol;   Dietary Supplement: EGCG + Tocotrienol
Outcome Measures: Changes in nasal chloride secretion as assessed by TEPD, with assessment of mean changes in TEPD by drug compared to baseline and the proportion of patients with a chloride secretion response by drug compared to baseline;   Pulmonary function testing: forced expiratory volume in 1 sec [FEV1], forced vital capacity [FVC], and maximal expiratory flow25-75 [MEF25-75]
14 Recruiting Trial of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
Condition: Prediabetes
Intervention: Dietary Supplement: herb and mineral combination product
Outcome Measures: Change from Baseline in fasting blood glucose;   Change from Baseline in fasting serum glucose;   Change from Baseline in HbA1c;   Change from Baseline in fasting lipids;   Change from Baseline in BMI;   Change from Baseline in waist-to-hip ratio
15 Recruiting Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease
Condition: Peyronie's Disease
Interventions: Drug: Vitamin D2;   Drug: Vitamin E;   Drug: Testosterone Pellets
Outcome Measures: penile curvature;   sexual function
16 Recruiting Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: AquADEKs-2;   Dietary Supplement: control multivitamin
Outcome Measures: Change in Sputum Myeloperoxidase (MPO) Level;   Number of Adverse Events;   Change in Systemic Antioxidant Levels;   Change in Systemic Markers of Inflammation and Oxidative Stress;   Change in Sputum Markers of Inflammation and Oxidative Stress;   Change in Systemic Vitamin Levels;   Changes in Lung Function Endpoints;   Change in Growth Endpoints;   Time to Pulmonary Exacerbation;   Number of Pulmonary Exacerbations;   Number of hospitalizations
17 Recruiting Effect of Tomato Extracted Lycopene on Postprandial Oxidation and inflammation in Healthy Weight Men and Women
Condition: Postprandial Oxidation and inflammation
Interventions: Dietary Supplement: Tomato extracted lycopene;   Dietary Supplement: Placebo
Outcome Measures: Reduction of postprandial Oxidized LDL(OX-LDL) levels following 2 weeks of supplementation with tomato extracted lycopene;   Reduction of postprandial triglycerides, glucose, insulin and hsCRP levels following 2 weeks of supplementation with tomato extracted lycopene
18 Recruiting Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function
Conditions: Renal Function;   Endothelial Function;   Blood Pressure;   Overweight;   Obesity
Interventions: Drug: Vitamin D ergocalciferol;   Drug: Probenecid;   Drug: Allopurinol;   Drug: Placebo
Outcome Measures: kidney specific renin angiotensin system (RAS) activation;   systemic renin angiotensin system (RAS) activation;   endothelial function;   Ambulatory Blood Pressure
19 Recruiting Vitamin D and Type 2 Diabetes Study
Conditions: Prediabetes;   Type 2 Diabetes
Interventions: Dietary Supplement: Vitamin D (Cholecalciferol);   Other: Placebo
Outcome Measures: Time to development of diabetes;   Measurement of plasma 25OHD concentration.;   Number of participants with adverse events as a measure of the safety of vitamin D supplementation.;   Blood Pressure;   Variability of response to vitamin D supplementation by baseline characteristic: BMI;   Variability of response to vitamin D supplementation by baseline characteristic: waist circumference;   Variability of response to vitamin D supplementation by baseline characteristic: age;   Variability of response to Vitamin D supplementation by baseline characteristic: geographic location (as a proxy for sun exposure);   Variability of response to vitamin D supplementation by baseline characteristic: calcium intake;   Variability of response to vitamin D supplementation by baseline characteristic: 25OHD concentration;   Variability of response to vitamin D supplementation by baseline characteristic: race (as a proxy for skin pigmentation);   Number of participants who discontinue study pills as a measure of the tolerability of vitamin D supplementation.;   Change in FPG as a continuous variable.;   Change in 2hPG as a continuous variable.;   Measurement of insulin resistance (derived from the OGTT).;   Measurement of beta cell secretion (derived from the OGTT);   Identification of characteristics associated with the variability in achieved 25-hydroxycholecalciferol (25OHD) concentration.;   Change in HbA1c as a continuous variable.
20 Recruiting The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: ARN-509;   Drug: LHRH Agonist
Outcome Measures: Mean change in quality of life (QOL) measured by total FACT-P score;   Quality of Life Instruments;   PSA Modulation;   Metabolic and Hormonal Changes;   Toxicity